WO2006020302A3 - Biomarqueurs du cancer de la vessie - Google Patents

Biomarqueurs du cancer de la vessie Download PDF

Info

Publication number
WO2006020302A3
WO2006020302A3 PCT/US2005/025632 US2005025632W WO2006020302A3 WO 2006020302 A3 WO2006020302 A3 WO 2006020302A3 US 2005025632 W US2005025632 W US 2005025632W WO 2006020302 A3 WO2006020302 A3 WO 2006020302A3
Authority
WO
WIPO (PCT)
Prior art keywords
biomarkers
bladder cancer
useful
qualifying
classify
Prior art date
Application number
PCT/US2005/025632
Other languages
English (en)
Other versions
WO2006020302A2 (fr
Inventor
Antonia Vlahou
O John Semmes
Original Assignee
Eastern Virginia Med School
Antonia Vlahou
O John Semmes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Med School, Antonia Vlahou, O John Semmes filed Critical Eastern Virginia Med School
Priority to AU2005274726A priority Critical patent/AU2005274726A1/en
Priority to US11/632,423 priority patent/US20080026410A1/en
Priority to EP05804464A priority patent/EP1784499A4/fr
Priority to CA002574831A priority patent/CA2574831A1/fr
Publication of WO2006020302A2 publication Critical patent/WO2006020302A2/fr
Publication of WO2006020302A3 publication Critical patent/WO2006020302A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne des biomarqueurs ainsi que des combinaisons de biomarqueurs à base de protéines qui sont utiles pour qualifier l'état d'un cancer de la vessie chez un patient. Les biomarqueurs de cette invention sont notamment utiles pour classifier un échantillon prélevé sur un sujet comme indiquant un cancer de la vessie ou pas de cancer de la vessie. Les biomarqueurs peuvent être détectés par spectrométrie de masse SELDI.
PCT/US2005/025632 2004-07-23 2005-07-20 Biomarqueurs du cancer de la vessie WO2006020302A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2005274726A AU2005274726A1 (en) 2004-07-23 2005-07-20 Biomarkers for bladder cancer
US11/632,423 US20080026410A1 (en) 2004-12-02 2005-07-20 Biomarkers for Bladder Cancer
EP05804464A EP1784499A4 (fr) 2004-07-23 2005-07-20 Biomarqueurs du cancer de la vessie
CA002574831A CA2574831A1 (fr) 2004-07-23 2005-07-20 Biomarqueurs du cancer de la vessie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59035004P 2004-07-23 2004-07-23
US60/590,350 2004-07-23

Publications (2)

Publication Number Publication Date
WO2006020302A2 WO2006020302A2 (fr) 2006-02-23
WO2006020302A3 true WO2006020302A3 (fr) 2006-06-08

Family

ID=35908003

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/025632 WO2006020302A2 (fr) 2004-07-23 2005-07-20 Biomarqueurs du cancer de la vessie

Country Status (4)

Country Link
EP (1) EP1784499A4 (fr)
AU (1) AU2005274726A1 (fr)
CA (1) CA2574831A1 (fr)
WO (1) WO2006020302A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8983580B2 (en) 2008-01-18 2015-03-17 The Board Of Trustees Of The University Of Illinois Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775590A1 (fr) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Procédé non invasif pour la détection in vitro du carcinome transitionnel de la vessie
US8945511B2 (en) 2009-06-25 2015-02-03 Paul Weinberger Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
EP2602621A1 (fr) * 2011-12-08 2013-06-12 Julius-Maximilians-Universität Würzburg LASP-1, nouveau marqueur urinaire pour la détection du carcinome cellulaire transitionnel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320549A1 (fr) * 2000-09-25 2002-03-25 Eastern Virginia Medical College Biomarqueurs de carcinome transitionnel de la vessie
EP1485461A4 (fr) * 2002-02-21 2005-06-22 Eastern Virginia Med School Biomarqueurs de proteines distinguant le cancer de la prostate de cellules non malignes
US20050176011A1 (en) * 2002-04-26 2005-08-11 Chan Daniel W. Identification of biomarkers for detecting prostate cancer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
See also references of EP1784499A4 *
SOLOWAY MS.: "Editorial: Bladder tumor markers, intravesical therapy and systemic chemotherapy.", JOURNAL OF UROLOGY., vol. 166, no. 2, August 2001 (2001-08-01), pages 488 - 489, XP008062374 *
VLAHOU A ET AL: "Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine.", AMERICAN JOURNAL OF PATHOLOGY., vol. 158, no. 4, 1 April 2001 (2001-04-01), pages 1491 - 1502, XP002201552 *
VLAHOU A ET AL: "Protein Profiling in Urine for the Diagnosis of Bladder Cancer.", CLINICAL CHEMISTRY., vol. 50, no. 8, August 2004 (2004-08-01), pages 1438 - 1441, XP002996185 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8983580B2 (en) 2008-01-18 2015-03-17 The Board Of Trustees Of The University Of Illinois Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors

Also Published As

Publication number Publication date
CA2574831A1 (fr) 2006-02-23
WO2006020302A2 (fr) 2006-02-23
EP1784499A4 (fr) 2007-08-22
EP1784499A2 (fr) 2007-05-16
AU2005274726A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
WO2006034032A3 (fr) Marqueurs biologiques destines au cancer du sein
WO2007002535A3 (fr) Biomarqueurs pour le cancer des ovaires
WO2007002264A3 (fr) Bio-marqueur pour cancer ovarien : protéines apparentées à ctap3
WO2006128082A3 (fr) Biomarqueurs du cancer du sein
WO2007002527A3 (fr) Biomarqueurs pour le cancer de l'ovaire: la b2-microglobuline
WO2007035766A3 (fr) Biomarqueur servant a detecter un cancer de la prostate
WO2006099126A3 (fr) Biomarqueurs du cancer de l'ovaire et de l'endometre: la hepcidine
WO2006089125A3 (fr) Méthodes de détection du cancer de l'ovaire
WO2006113289A3 (fr) Saposine d et fam3c utilises en tant que biomarqueurs de la maladie d'alzheimer
WO2009037572A3 (fr) Combinaisons de bio-marqueurs du cancer colorectal
WO2007087534A3 (fr) Procedes, melanges, kits et compositions appartenant à une determination de substances a analyser
WO2007118222A3 (fr) Compositions pour l'identification de champignons
WO2006074430A3 (fr) Biomarqueurs de melanome
WO2010102251A3 (fr) Protéines de liaison à il-17
WO2008005375A3 (fr) Biomarqueurs de la néphrotoxicité
WO2007002069A3 (fr) Biomarqueurs du cancer du sein
WO2007079229A3 (fr) Dispositifs et procedes d'enrichissement et de modification de cellules tumorales circulantes et d'autres particules
EP1880020A4 (fr) Dosage d'antioxydant a biomarqueur cellulaire et utilisations correspondantes
WO2009039307A3 (fr) Hydrogels et procédés de production et d'utilisation de ceux-ci
WO2010078945A3 (fr) Traitement du cancer
WO2009083950A3 (fr) Biomarqueurs pour prévoir l'apparition d'une lésion rénale
WO2008129296A3 (fr) Marqueurs de maladies
WO2006048262A3 (fr) Classification de la leucemie myeloblastique aigue
WO2006085121A3 (fr) Biomarqueurs et leurs utilisations
WO2007071874A3 (fr) Nouveaux composes interagissant avec pea-15

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005274726

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2574831

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2005274726

Country of ref document: AU

Date of ref document: 20050720

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005274726

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 553336

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2005804464

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11632423

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2005804464

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11632423

Country of ref document: US